[1] Malfertheiner P, Camargo M C, Elomar E, et al. Helicobacter pylori infection[J]. Nat Rev Dis Primers, 2023, 9: 19. doi: 10.1038/s41572-023-00431-8. [2] Burclaff J, Willet S G, Sáenz J B, et al. Proliferation and differentiation of gastric mucous neck and chief cells during homeostasis and injury-induced metaplasia[J]. Gastroenterology, 2020, 158: 598-609. [3] Liu X, Ma Z, Deng Z, et al. Role of spasmolytic polypeptide-expressing metaplasia in gastric mucosal diseases[J]. Am J Cancer Res, 2023, 13: 1667-1681. [4] Kuo HY, Chang WL, Yeh YC, et al. Serum level of trefoil factor 2 can predict the extent of gastric spasmolytic polypeptide-expressing metaplasia in the H. pylori-infected gastric cancer relatives[J]. Helicobacter, 2017, 22. doi: 10.1111/hel.12320. [5] Peterson AJ, Menheniott TR, O′connor L, et al. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans[J]. Gastroenterology, 2010, 139: 2005-2017. [6] Fox JG, Rogers AB, Whary MT, et al. Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2-/- C57BL6 x Sv129 Helicobacter pylori-infected mice[J]. Am J Pathol, 2007, 171: 1520-1528. [7] Tsai YC, Hsiao WH, Lin SH, et al. Genomic single nucleotide polymorphisms in the offspring of gastric cancer patients predispose to spasmolytic polypeptide-expressing metaplasia after H. pylori infection[J]. J Biomed Sci, 2015, 22: 16. doi: 10.1186/s12929-015-0121-7. [8] Ishimoto T, Izumi D, Watanabe M, et al. Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa[J]. J Gastroenterol, 2015, 50: 751-757. [9] Li ML, Hong XX, Zhang WJ, et al. Helicobacter pylori plays a key role in gastric adenocarcinoma induced by spasmolytic polypeptide-expressing metaplasia[J]. World J Clin Cases, 2023, 11: 3714-3724. [10] Kountouras J, Kapetanakis N. CD44 and Helicobacter pylori-related colon oncogenesis[J]. Saudi Med J, 2015, 36: 1249. doi: 10.15537/smj.2015.10.12510. [11] Xia J, Wang H, Li S, et al. Ion channels or aquaporins as novel molecular targets in gastric cancer[J]. Molecular Cancer, 2017, 16: 54. doi: 10.1186/s12943-017-0622-y. [12] Biagioni A, Peri S, Versienti G, et al. Gastric cancer vascularization and the contribution of reactive oxygen species[J]. Biomolecules, 2023, 13: 886. doi: 10.3390/biom13060886. [13] Li N, Xu X, Yang H, et al. Activation of aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial-mesenchymal transition via the MEK/ERK pathway[J]. Helicobacter, 2021, 26: e12842. doi: 10.1111/hel.12842. [14] Zuo W, Yang H, Li N, et al. Helicobacter pylori infection activates Wnt/β-catenin pathway to promote the occurr-ence of gastritis by upregulating ASCL1 and AQP5[J]. Cell Death Discov, 2022, 8: 257. doi: 10.1038/s41420-022-01026-0. [15] Hong X, Li H, Lin Y, et al. Efficacy and potential therapeutic mechanism of Weiwei decoction on Spasmolytic polypeptide-expressing metaplasia in Helicobacter pylori-infected and Atp4a-knockout mice[J]. J Ethnopharmacol, 2024, 319: 117062. doi: 10.1016/j.jep.2023.117062. [16] Wroblewski LE, Choi E, Petersen C, et al. Targeted mobilization of Lrig1(+) gastric epithelial stem cell populations by a carcinogenic Helicobacter pylori type Ⅳ secretion system[J]. Proc Natl Acad Sci U S A, 2019, 116: 19652-19658. [17] Hata M, Kinoshita H, Hayakawa Y, et al. GPR30-expressing gastric chief cells do not dedifferentiate but are eliminated via pdk-dependent cell competition during development of metaplasia[J]. Gastroenterology, 2020, 158: 1650-1666. [18] Bockerstett KA, Lewis SA, Noto CN, et al. Single-cell transcriptional analyses identify lineage-specific epithelial responses to inflammation and metaplastic development in the gastric corpus[J]. Gastroenterology, 2020, 159: 2116-2129. [19] Mejías-luque R, Lozano-Pope I, Wanisch A, et al. Increased LIGHT expression and activation of non-canonical NF-κB are observed in gastric lesions of MyD88-deficient mice upon Helicobacter felis infection[J]. Sci Rep, 2019, 9: 7030. doi: 10.1038/s41598-019-43417-x. [20] Xie Y, Liu L. Analysis of correlation between HP infection and activation of PI3K/Akt pathway in mucosal tissues of gastric cancer and precancerous lesions[J]. Oncol Lett, 2018, 16: 5615-5620. [21] Wang H, Zhao M, Shi F, et al. A review of signal pathway induced by virulent protein CagA of Helicobacter pylori[J]. Front Cell Infect Microbiol, 2023, 13: 1062803. doi: 10.3389/fcimb.2023.1062803. [22] Morningstar-Wright L, Czinn SJ, Piazuelo MB, et al. The TNF-alpha inducing protein is associated with gastric inflammation and hyperplasia in a murine model of Helicobacter pylori infection[J]. Front Pharmacol, 2022, 13: 817237. doi: 10.3389/fphar.2022.817237. [23] Tang CL, Hao B, Zhang G X, et al. Helicobacter pylori tumor necrosis factor-α inducing protein promotes cytokine expression via nuclear factor-κB[J]. World J Gastroenterol, 2013, 19: 399-403. [24] Arnold IC, Lee JY, Amieva MR, et al. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia[J]. Gastroenterology, 2011, 140: 199-209. [25] Krueger S, Kuester D, Bernhardt A, et al. Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages[J]. J Pathol, 2009, 217: 581-588. |